Why the study?
Does doxepin have fewer cardiovascular effects compared to other tricyclic antidepressants?
Does doxepin have fewer cardiovascular effects compared to other tricyclic antidepressants?
Contrary to early reports, doxepin does not appear to have fewer cardiovascular side effects than other tricyclic antidepressants.
Answers are grounded in this paper and cite their sources.
Comparable cardiac effects to other tricyclics warrant equivalent caution; challenges early reports but leaves open differential safety in prospective data.
On the basis of early reports suggesting that doxepin has fewer cardiovascular effects than do other tricyclic antidepressants, doxepin continues to be recommended for the treatment of depression in cardiac patients and in the elderly. However, these reports have been criticized, and other evidence has suggested opposite conclusions. To clarify this issue, the author reviewed clinical and animal studies and found that, in general, doxepin has an effect comparable to the effects of other tricyclic antidepressants on cardiac conduction, cardiac rhythm, heart rate, blood pressure, and cardiac mechanics.
No takes yet. Share an insight, caveat, or question.
Daniel J. Luchins (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: